WallStSmart

Shell PLC ADR (SHEL)vsUranium Royalty Corp (UROY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Shell PLC ADR generates 158551% more annual revenue ($296.60B vs $186.95M). UROY leads profitability with a 21.5% profit margin vs 8.8%. SHEL trades at a lower P/E of 10.3x. SHEL earns a higher WallStSmart Score of 73/100 (B).

SHEL

Strong Buy

73

out of 100

Grade: B

Growth: 7.3Profit: 6.5Value: 5.3Quality: 6.0
Piotroski: 3/9Altman Z: 2.37

UROY

Buy

59

out of 100

Grade: C

Growth: 10.0Profit: 7.5Value: 6.0Quality: 9.0
Piotroski: 4/9Altman Z: 5.14
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

SHELSignificantly Overvalued (-63.0%)

Margin of Safety

-63.0%

Fair Value

$58.46

Current Price

$96.77

$38.31 premium

UndervaluedFair: $58.46Overvalued

Intrinsic value data unavailable for UROY.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SHEL6 strengths · Avg: 10.0/10
Market CapQuality
$266.01B10/10

Mega-cap, among the largest globally

P/E RatioValuation
10.3x10/10

Attractively priced relative to earnings

Price/BookValuation
1.5x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
44.7%10/10

Revenue surging 44.7% year-over-year

EPS GrowthGrowth
220.0%10/10

Earnings expanding 220.0% YoY

Free Cash FlowQuality
$17.40B10/10

Generating 17.4B in free cash flow

UROY6 strengths · Avg: 9.8/10
Operating MarginProfitability
32.1%10/10

Strong operational efficiency at 32.1%

Revenue GrowthGrowth
4343.0%10/10

Revenue surging 4343.0% year-over-year

EPS GrowthGrowth
462.2%10/10

Earnings expanding 462.2% YoY

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
5.1410/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
21.5%9/10

Keeps 22 of every $100 in revenue as profit

Areas to Watch

SHEL2 concerns · Avg: 3.5/10
PEG RatioValuation
1.564/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

UROY2 concerns · Avg: 3.0/10
Market CapQuality
$1.69B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
1.1%3/10

ROE of 1.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : SHEL

The strongest argument for SHEL centers on Market Cap, P/E Ratio, Price/Book. Revenue growth of 44.7% demonstrates continued momentum.

Bull Case : UROY

The strongest argument for UROY centers on Operating Margin, Revenue Growth, EPS Growth. Profitability is solid with margins at 21.5% and operating margin at 32.1%. Revenue growth of 4343.0% demonstrates continued momentum.

Bear Case : SHEL

The primary concerns for SHEL are PEG Ratio, Piotroski F-Score.

Bear Case : UROY

The primary concerns for UROY are Market Cap, Return on Equity.

Key Dynamics to Monitor

SHEL profiles as a hypergrowth stock while UROY is a growth play — different risk/reward profiles.

UROY carries more volatility with a beta of 1.42 — expect wider price swings.

UROY is growing revenue faster at 4343.0% — sustainability is the question.

SHEL generates stronger free cash flow (17.4B), providing more financial flexibility.

Bottom Line

SHEL scores higher overall (73/100 vs 59/100) and 44.7% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Shell PLC ADR

ENERGY · OIL & GAS INTEGRATED · USA

Shell plc is a global petrochemical and energy company. The company is headquartered in The Hague, the Netherlands.

Visit Website →

Uranium Royalty Corp

ENERGY · URANIUM · USA

Uranium Royalty Corp. The company is headquartered in Vancouver, Canada.

Visit Website →

Want to dig deeper into these stocks?